Meeder Asset Management Inc Coh Bar, Inc. Transaction History

Meeder Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$1.09 - $1.49 $1 - $1	-1 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$1.26 - $2.02 $1 - $2	1 New	1 $0
Q2 2019 Aug 05, 2019	SELL	$1.63 - $3.3 $624 - $1,263	-383 Closed	0 $0
Q1 2019 Apr 16, 2019	BUY	$2.95 - $4.16 $73 - $104	25 Added 6.98%	383 $1,000
Q4 2018 Jan 17, 2019	SELL	$2.97 - $4.52 $10,626 - $16,172	-3,578 Reduced 90.9%	358 $1,000
Q3 2018 Nov 02, 2018	BUY	$4.13 - $6.84 $16,255 - $26,922	3,936 New	3,936 $0

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.57M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.